CFTR and cystic fibrosis: In a primary culture model of CF-HBE considered the gold standard for evaluating CF therapeutics,14,15 we demonstrated that RFFL ASO effectively downregulates endogenous RFFL expression and improves ΔF508-CFTR function, thereby potentiating the efficacy of existing CFTR modulators.